130
Participants
Start Date
December 12, 2022
Primary Completion Date
January 31, 2026
Study Completion Date
March 31, 2026
Embrace HES including Instylla™ Delivery Kit and Instylla™ Microcatheter
The Embrace Hydrogel Embolic System (HES) is indicated for embolization of peripheral arterial bleeds in vessels ≤6mm
COMPLETED
Mount Sinai Hospital, New York
COMPLETED
Columbia University Milstein, New York
RECRUITING
University of Pittsburgh, Pittsburgh
RECRUITING
University of Pennsylvania, Philadelphia
RECRUITING
Medstar Georgetown University, Washington D.C.
RECRUITING
University of Maryland, Baltimore
COMPLETED
UNC School of Medicine, Chapel Hill
COMPLETED
Prisma Health, Greenville
RECRUITING
University of Miami, Miami
RECRUITING
University of Cincinnati, Cincinnati
COMPLETED
Indiana University, Indianapolis
COMPLETED
Medical College of Wisconsin, Milwaukee
RECRUITING
Northwestern, Evanston
RECRUITING
University of Oklahoma, Oklahoma City
RECRUITING
Banner Health, Phoenix
RECRUITING
UCLA Harbor Lindquist Institute, Torrance
RECRUITING
Memorial Health Services, Long Beach
RECRUITING
Stanford University, Stanford
COMPLETED
Nuvance Health, Danbury
RECRUITING
Yale University, New Haven
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Boston Medical Center, Boston
Lead Sponsor
Instylla, Inc.
INDUSTRY